290
Views
46
CrossRef citations to date
0
Altmetric
Research Article

In vitro toxicity of silver nanoparticles on murine peritoneal macrophages

, &
Pages 135-140 | Received 17 Mar 2010, Accepted 19 Apr 2010, Published online: 27 May 2010
 

Abstract

Silver nanoparticles, the new generation of antimicrobial agents, are becoming one of the progressively growing products in nanotechnology. Meanwhile, the potential side effects of these nanoparticles have not been studied thoroughly yet. Macrophages, one of the most important immune cells in innate and acquired immune responses, are a key component of the clearance mechanisms in semi-open interfaces of human body against nanosilver (nano-Ag). In this experimental study, we assessed the effect of commercial colloidal nano-Ag on murine peritoneal macrophages by MTT and nitric oxide (NO) production assay in vitro. A significant decrease in cell viability was observed for 1 ppm (part per million) to 25 ppm of nano-Ag concentrations compared to the control group (P < 0.01) after 24 h of cell culture. Also, a significant decrease in the cell viability was observed for 2–25 ppm of nano-Ag concentrations after 48–72 h, respectively (P < 0.05). In our study, exposure to 0.4–25 ppm of colloidal nano-Ags brought about a considerable decline (P < 0.05) in NO production by macrophages. Nevertheless, there is no evidence of substantial difference at lower concentrations. This acute cytotoxic dose-dependent effect of nano-Ag particles on peritoneal macrophages which declines cell viability and NO production urges caution about the usage for sensitive surfaces. It is highly recommended to carry out the in vivo investigation for human to confirm its use.

Acknowledgement

Authors wish to thank Dr. Roya Yaraee for her helpful discussion during the work.

Declaration of interest

This work was supported by Shahed University research grant.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.